Porter Derrell
SEC insider (Form 3/4/5 filer). CIK 0001706400. Director at Acumen Pharmaceuticals, Inc. (ABOS) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in NEWTON, MA.
Companies Porter Derrell has filed insider reports for
- Acumen Pharmaceuticals, Inc. (ABOS): Director
- Passage BIO, Inc. (PASG): Director
Porter Derrell
CIK: 0001706400
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 17, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect13K shares at avg. $2.33$30K - Jun 17, 2026ABOS
Acumen Pharmaceuticals, Inc.
ExerciseDirect13K shares at avg. $1.07$14K - Jun 16, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect12.8K shares at avg. $2.33$30K - Jun 15, 2026ABOS
Acumen Pharmaceuticals, Inc.
ExerciseDirect6.5K shares at avg. $1.07$7K - Jun 15, 2026ABOS
Acumen Pharmaceuticals, Inc.
SaleDirect6.5K shares at avg. $2.35$15K - Jun 3, 2026ABOS
Acumen Pharmaceuticals, Inc.
AwardDirect35.5K shares- - May 19, 2026PASG
Passage BIO, Inc.
AwardDirectDirector Stock Option (right to buy)
10.5K shares- - Jun 4, 2025ABOS
Acumen Pharmaceuticals, Inc.
AwardDirect12.8K shares- - May 28, 2025PASG
Passage BIO, Inc.
AwardDirectDirector Stock Option (right to buy)
201.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  ABOS Acumen Pharmaceuticals, Inc. | Sale | 13,040 | $2.33 | $30,318 | Direct |
| Jun 17, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Exercise | 13,040 | $1.07 | $13,953 | Direct |
| Jun 16, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 12,800 | $2.33 | $29,773 | Direct |
| Jun 15, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Exercise | 6,460 | $1.07 | $6,912 | Direct |
| Jun 15, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Sale | 6,460 | $2.35 | $15,149 | Direct |
| Jun 3, 2026 | ABOS Acumen Pharmaceuticals, Inc. | Award | 35,500 | - | $0 | Direct |
| May 19, 2026 |  PASG Passage BIO, Inc. | Award Director Stock Option (right to buy) | 10,539 | - | - | Direct |
| Jun 4, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Award | 12,800 | - | - | Direct |
| May 28, 2025 | PASG Passage BIO, Inc. | Award Director Stock Option (right to buy) | 201,857 | - | - | Direct |
1-9 of 9 transactions